Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBS | P35520 | 1/20 | 0.74 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.49 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.47 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3296522 | 1.00 | CBS (0.74) | CBSPTGS2EP300KAT2BKAT5 | |
| SCHEMBL2467234 | 1.00 | CBS (0.74) | CBSPTGS2EP300KAT2BKAT5 | |
| SCHEMBL4273283 | 0.88 | CBS (0.96) | CBSPTGS2CYP3A4 | |
| SCHEMBL13456991 | 0.86 | CBS (0.55) | CBSPTGS2EP300KAT2BKAT5 | |
| SCHEMBL16174035 | 0.86 | PTGS2 (0.57) | CBSPTGS2CNR1CNR2 | |
| SCHEMBL3486974 | 0.86 | CBS (1.00) | CBSPTGS2CYP3A4 | |
| Cardanol SCHEMBL2290369 | 0.84 | CBS (0.53) | CBSEP300KAT2BKAT5KAT8 | |
| Cardanol SCHEMBL2687568 | 0.84 | CBS (0.53) | CBSEP300KAT2BKAT5KAT8 | |
| Cardanol SCHEMBL4173456 | 0.84 | CBS (0.53) | CBSEP300KAT2BKAT5KAT8 | |
| Cardanol SCHEMBL29973669 | 0.84 | CBS (0.53) | CBSEP300KAT2BKAT5KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |